ANG Lifesciences India Ltd

ANG Lifesciences India Ltd

₹ 45.1 -3.74%
28 Mar - close price
About

Incorporated in 2006, ANG Lifesciences India Ltd manufactures and markets finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials[1]

Key Points

Business Overview:[1][2]
Company manufactures and sells products like injections, tablets, capsules, syrups, ointments of different varieties. It deals in 4 market segments: institutional segment, third party manufacturing, direct marketing and export market. Apart from this, company is also providing printing & packing solutions especially in mono cartons, paper printing, corrugation, aluminiumfoils (blister foils)

  • Market Cap 58.9 Cr.
  • Current Price 45.1
  • High / Low 92.2 / 44.5
  • Stock P/E
  • Book Value 65.7
  • Dividend Yield 0.00 %
  • ROCE 8.92 %
  • ROE -0.21 %
  • Face Value 10.0

Pros

  • Stock is trading at 0.69 times its book value

Cons

  • Company has low interest coverage ratio.
  • Promoters have pledged 44.9% of their holding.
  • Earnings include an other income of Rs.9.74 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2020 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
32.21 119.87 89.46 49.61 95.38 73.71 59.82 46.93 39.44 56.46 33.26 18.55
30.51 90.39 69.61 44.29 82.64 61.70 50.17 44.17 49.72 49.92 31.60 20.46
Operating Profit 1.70 29.48 19.85 5.32 12.74 12.01 9.65 2.76 -10.28 6.54 1.66 -1.91
OPM % 5.28% 24.59% 22.19% 10.72% 13.36% 16.29% 16.13% 5.88% -26.06% 11.58% 4.99% -10.30%
0.04 0.08 0.10 0.16 0.57 0.09 0.16 0.24 9.23 0.32 0.22 -0.03
Interest 0.93 1.37 1.64 2.00 3.92 3.44 3.31 3.47 1.65 2.31 2.29 2.51
Depreciation 0.35 0.54 1.20 1.53 2.61 2.09 2.11 2.13 3.03 2.19 2.22 1.91
Profit before tax 0.46 27.65 17.11 1.95 6.78 6.57 4.39 -2.60 -5.73 2.36 -2.63 -6.36
Tax % 54.35% 27.59% 24.96% 34.36% 22.57% 46.73% 40.09% 31.92% 19.55% 25.85% 12.17% 6.92%
0.22 20.03 12.84 1.27 5.25 3.49 2.63 -1.78 -4.61 1.75 -2.32 -5.93
EPS in Rs 0.17 15.41 9.88 0.98 4.04 2.68 2.03 -1.36 -3.53 1.34 -1.78 -4.54
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023 TTM
154 354 220 148
140 286 205 152
Operating Profit 14 68 15 -4
OPM % 9% 19% 7% -3%
1 1 10 10
Interest 4 9 12 9
Depreciation 1 6 9 9
Profit before tax 10 54 3 -12
Tax % 31% 25% 110%
7 40 -0 -11
EPS in Rs 5.26 31.02 -0.20 -8.51
Dividend Payout % -0% 3% -0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -46%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -216%
Stock Price CAGR
10 Years: %
5 Years: 19%
3 Years: 9%
1 Year: -40%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 0%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Sep 2023
Equity Capital 10 13 13
Reserves 73 73 73
77 73 72
130 119 111
Total Liabilities 290 278 269
93 88 86
CWIP -0 -0 -0
Investments 0 0 0
198 190 184
Total Assets 290 278 269

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023
25 26
-44 -9
20 -17
Net Cash Flow 0 -0

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Mar 2022 Mar 2023
Debtor Days 105 138
Inventory Days 59 118
Days Payable 113 165
Cash Conversion Cycle 51 91
Working Capital Days 78 114
ROCE % 9%

Shareholding Pattern

Numbers in percentages

2 Recently
Mar 2020Sep 2020Mar 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
71.01% 71.01% 71.01% 71.07% 71.09% 71.14% 71.15% 71.15% 71.15% 70.60% 70.60% 70.60%
28.99% 28.99% 28.99% 28.93% 28.91% 28.86% 28.85% 28.86% 28.85% 29.40% 29.38% 29.41%
No. of Shareholders 3343563283232,5224,2595,2156,9396,9467,1637,3057,055

Documents